Δευτέρα 8 Αυγούστου 2016

Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

Conditions:   Recurrent Head and Neck Carcinoma;   Head and Neck Cancer Metastatic;   Head or Neck Cancer
Interventions:   Radiation: Intensity Modulated Radiation Therapy (IMRT);   Drug: Cisplatin;   Radiation: Stereotactic Body Radiotherapy (SBRT)
Sponsor:   Dana-Farber Cancer Institute
Recruiting - verified August 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/2b7OEpJ
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου